Ai Proteins, Inc. announced it raised $11.3 Million in an initial filing from an offering of $18.2 Million

Company

Location

About

AI Proteins is a Boston-based biotech company reimagining protein therapeutics through AI-enabled design and a high-throughput discovery platform. The company creates entirely de novo miniproteins optimized for diverse therapeutic applications and partners with leading biopharmaceutical companies while advancing its own pipeline. Its platform dramatically accelerates the development of lead candidates ready for IND-enabling studies.